BIOMAT Database Logo BIOMAT Database Logo

[Selective inhibition of type A monoamine oxidase by pyrazidol]. 1981

M D Mashkovskiĭ, and V Z Gorkin, and I V Verevkina, and V V Asnina, and S M Tupikina

Effect of a new antidepressant pyrazidol (1,10-trimethylene-8-methyl-1,2,3,4-tetrahydropyrazino /1,2-/ indole) on the liver and brain MAO activity of rats was studied in experiments in vivo and in vitro. Pyrazidol selectively blocks type A MAO (the substrates serotonin and noradrenaline) and does not virtually affect or has a far less action on type B MAO (the substrate 2-phenylethylamine).

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008297 Male Males
D008930 Mitochondria, Liver Mitochondria in hepatocytes. As in all mitochondria, there are an outer membrane and an inner membrane, together creating two separate mitochondrial compartments: the internal matrix space and a much narrower intermembrane space. In the liver mitochondrion, an estimated 67% of the total mitochondrial proteins is located in the matrix. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p343-4) Liver Mitochondria,Liver Mitochondrion,Mitochondrion, Liver
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D010627 Phenethylamines A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed) Phenylethylamines
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002227 Carbazoles Benzo-indoles similar to CARBOLINES which are pyrido-indoles. In plants, carbazoles are derived from indole and form some of the INDOLE ALKALOIDS.
D003641 Deamination The removal of an amino group (NH2) from a chemical compound. Deaminations
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine

Related Publications

M D Mashkovskiĭ, and V Z Gorkin, and I V Verevkina, and V V Asnina, and S M Tupikina
Selective inhibition of monoamine oxidase type B by chlormethiazole.
January 1987, Alcohol and alcoholism (Oxford, Oxfordshire),
M D Mashkovskiĭ, and V Z Gorkin, and I V Verevkina, and V V Asnina, and S M Tupikina
Selective inhibition of monoamine oxidase A by hispidol.
February 2018, Bioorganic & medicinal chemistry letters,
M D Mashkovskiĭ, and V Z Gorkin, and I V Verevkina, and V V Asnina, and S M Tupikina
Selective inhibition of monoamine oxidase.
January 1972, Advances in biochemical psychopharmacology,
M D Mashkovskiĭ, and V Z Gorkin, and I V Verevkina, and V V Asnina, and S M Tupikina
Selective inhibition by amezinium of intraneuronal monoamine oxidase.
October 1980, Naunyn-Schmiedeberg's archives of pharmacology,
M D Mashkovskiĭ, and V Z Gorkin, and I V Verevkina, and V V Asnina, and S M Tupikina
Phenylhydrazine: selective inhibition of human brain type B monoamine oxidase.
May 1981, Biochemical pharmacology,
M D Mashkovskiĭ, and V Z Gorkin, and I V Verevkina, and V V Asnina, and S M Tupikina
Selective inhibition of monoamine oxidase A by purpurin, an anthraquinone.
March 2017, Bioorganic & medicinal chemistry letters,
M D Mashkovskiĭ, and V Z Gorkin, and I V Verevkina, and V V Asnina, and S M Tupikina
[Mechanism of the qualitative modification of mitochondrial monoamine oxidase activity by pyrazidol].
January 1987, Voprosy meditsinskoi khimii,
M D Mashkovskiĭ, and V Z Gorkin, and I V Verevkina, and V V Asnina, and S M Tupikina
Substrate selective inhibition of monoamine oxidase by mexiletine [proceedings].
September 1977, British journal of pharmacology,
M D Mashkovskiĭ, and V Z Gorkin, and I V Verevkina, and V V Asnina, and S M Tupikina
Selective inhibition by amiflamine of monoamine oxidase type A in rat brain, liver and duodenum.
August 1984, Naunyn-Schmiedeberg's archives of pharmacology,
M D Mashkovskiĭ, and V Z Gorkin, and I V Verevkina, and V V Asnina, and S M Tupikina
SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.
January 1987, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!